These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32868832)

  • 1. The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8.
    Guttman M; Padte NN; Huang Y; Yu J; Rocklin GJ; Weitzner BD; Scian M; Ho DD; Lee KK
    Sci Rep; 2020 Aug; 10(1):14313. PubMed ID: 32868832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography.
    Do Kwon Y; Wang XE; Bender MF; Yang R; Li Y; McKee K; Rawi R; O'Dell S; Schneck NA; Shaddeau A; Zhang B; Arnold FJ; Connors M; Doria-Rose NA; Kwong PD; Lei QP
    Antibodies (Basel); 2021 Jun; 10(2):. PubMed ID: 34200826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibody.
    Masiero A; Nelly L; Marianne G; Christophe S; Florian L; Ronan C; Claire B; Cornelia Z; Grégoire B; Eric L; Ludovic L; Dominique B; Sylvie A; Marie G; Francis D; Fabienne S; Cécile C; Isabelle A; Jacques D; Jérôme D; Bruno G; Katarina R; Jean-Michel M; Catherine P
    MAbs; 2020; 12(1):1698128. PubMed ID: 31791173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.
    O'Neal KD; Chari MV; Mcdonald CH; Cook RG; Yu-Lee LY; Morrisett JD; Shearer WT
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):833-44. PubMed ID: 8645165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
    Kwon YD; Georgiev IS; Ofek G; Zhang B; Asokan M; Bailer RT; Bao A; Caruso W; Chen X; Choe M; Druz A; Ko SY; Louder MK; McKee K; O'Dell S; Pegu A; Rudicell RS; Shi W; Wang K; Yang Y; Alger M; Bender MF; Carlton K; Cooper JW; Blinn J; Eudailey J; Lloyd K; Parks R; Alam SM; Haynes BF; Padte NN; Yu J; Ho DD; Huang J; Connors M; Schwartz RM; Mascola JR; Kwong PD
    J Virol; 2016 Jul; 90(13):5899-5914. PubMed ID: 27053554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.
    Rujas E; Leaman DP; Insausti S; Ortigosa-Pascual L; Zhang L; Zwick MB; Nieva JL
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of i and i+3 residue identity on cis-trans isomerism of the aromatic(i+1)-prolyl(i+2) amide bond: implications for type VI beta-turn formation.
    Meng HY; Thomas KM; Lee AE; Zondlo NJ
    Biopolymers; 2006; 84(2):192-204. PubMed ID: 16208767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential HIV-1 fusion inhibitors mimicking gp41-specific broadly neutralizing antibody 10E8: In silico discovery and prediction of antiviral potency.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Bioinform Comput Biol; 2018 Apr; 16(2):1840007. PubMed ID: 29439644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime.
    Yu Y; Tong P; Li Y; Lu Z; Chen Y
    Sci China Life Sci; 2014 Jan; 57(1):117-27. PubMed ID: 24369352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin.
    Hur S; Bruice TC
    J Am Chem Soc; 2002 Jun; 124(25):7303-13. PubMed ID: 12071739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene.
    Sun Z; Zhu Y; Wang Q; Ye L; Dai Y; Su S; Yu F; Ying T; Yang C; Jiang S; Lu L
    Emerg Microbes Infect; 2016 Jun; 5(6):e65. PubMed ID: 27329850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalysis of proline isomerization and molecular chaperone activity in a tug-of-war.
    Favretto F; Flores D; Baker JD; Strohäker T; Andreas LB; Blair LJ; Becker S; Zweckstetter M
    Nat Commun; 2020 Nov; 11(1):6046. PubMed ID: 33247146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of azaproline on Peptide conformation.
    Che Y; Marshall GR
    J Org Chem; 2004 Dec; 69(26):9030-42. PubMed ID: 15609935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of proline cis-trans isomerization on TB domain secondary structure.
    Yuan X; Werner JM; Knott V; Handford PA; Campbell ID; Downing K
    Protein Sci; 1998 Oct; 7(10):2127-35. PubMed ID: 9792099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insight into proline
    Kawagoe S; Nakagawa H; Kumeta H; Ishimori K; Saio T
    J Biol Chem; 2018 Sep; 293(39):15095-15106. PubMed ID: 30093407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling between trans/cis proline isomerization and protein stability in staphylococcal nuclease.
    Truckses DM; Somoza JR; Prehoda KE; Miller SC; Markley JL
    Protein Sci; 1996 Sep; 5(9):1907-16. PubMed ID: 8880915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
    Virology; 2017 May; 505():113-126. PubMed ID: 28237764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.
    Irimia A; Serra AM; Sarkar A; Jacak R; Kalyuzhniy O; Sok D; Saye-Francisco KL; Schiffner T; Tingle R; Kubitz M; Adachi Y; Stanfield RL; Deller MC; Burton DR; Schief WR; Wilson IA
    PLoS Pathog; 2017 Feb; 13(2):e1006212. PubMed ID: 28225819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
    Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.